XML 41 R12.htm IDEA: XBRL DOCUMENT v3.22.1
Investments
12 Months Ended
Dec. 31, 2021
Investments  
Investments

4. Investments

The following table summarizes the Group’s investment balances:

As of December 31, 

(Amount in Thousands)

    

2020

    

2021

    

2021

RMB

RMB

US$

Short-term investments

 

  

 

  

 

  

Held-to-maturity investments

 

114,928

 

29,288

 

4,596

Available-for-sale investments

 

 

13,805

2,166

Trading debt securities

 

 

14,804

2,323

Equity securities measured at fair value

 

 

7,925

1,244

Investments held by consolidated investment funds measured at fair value

26,981

4,234

Total short-term investments

 

114,928

 

92,803

14,563

Long-term investments

 

  

 

 

Available-for-sale investments

 

14,135

 

 

Investments held by consolidated investment funds measured at fair value

 

74,498

 

80,327

12,605

- Other long-term investments

 

  

 

 

- Investments measured at fair value

 

285,045

 

376,957

59,153

- Investments measured at cost less impairment

 

 

 

- Private equity funds products

 

100,295

 

96,302

15,112

- Other investments measured at cost less impairment

 

62,411

 

114,986

18,044

Total other long-term investments

 

447,751

 

588,245

92,309

Total long-term investments

 

536,384

 

668,572

104,914

Total investments

 

651,312

 

761,375

119,477

Held-to-maturity investments consist of investments managed by the Group that have stated maturity and normally pay a prospective fixed or floating rate of return, carried at amortized cost. The Group recorded investment income on these products of RMB5,711, RMB10,311 and RMB1,568 for the years ended December 31, 2019, 2020 and 2021, respectively. The gross unrecognized holding gain was RMB5,087 and RMB612 as of December 31, 2020 and 2021, respectivley. Due to the credit deterioration of certain held-to-maturity investments, an other-than-temporary impairment loss of RMB104,365 was recognized and recorded in investment income (loss) for the year ended December 31, 2019. No credit loss related to held-to-maturity investments was recognized for the years ended December 31, 2020 and 2021.

Available-for-sale investments consist of investments managed by the Group that have stated maturity and normally pay a prospective fixed rate of return, carried at fair value. All of available-for-sale investments as of December 31, 2021 of RMB13,805 will mature in 2022. Changes in fair value of the available-for-sale investments, net of tax, for the years ended December 31, 2019, 2020 and 2021 was RMB4,306, RMB(4) and RMB243, respectively, recorded in the other comprehensive income (loss), of which RMB5,103, RMB(775) and RMB243 was realized and reclassified from other comprehensive income (loss) to investment income (loss) in the consolidated statements of operations for the years ended December 31, 2019, 2020 and 2021. The amortized cost of the available-for-sale investments as of December 31, 2020 and 2021 was RMB14,135 and RMB13,805, respectively. No other-than-temporary impairment for available-for-sale investments was recognized for the year ended December 31, 2019, and no credit loss was recognized for the years ended December 31, 2020 and 2021.

The consolidated investment funds are, for GAAP purposes, investment companies and reflect their investments at fair value. The Group has retained this specialized accounting for the consolidated funds in consolidation. Accordingly, the unrealized gains and losses resulting from changes in fair value of the investments held by the consolidated investment funds are recorded in the consolidated statements of operations as investment income.

Other long-term investments consist of investments in several private equity funds as a limited partner with insignificant equity interest and equity investments of common shares of several companies with less than 20% interest. The Group elects to measure these investments at fair value or at cost, less impairment. The Group recognized impairment loss related to investments measured at cost, less impairment, of nil, RMB115,100 and RMB10,000 in investment income (loss) for the years ended December 31, 2019, 2020 and 2021, respectively. The impairment in 2020 was due to the deteriorating operation of a single investment and measured as the difference between the investment’s carrying amount and fair value estimated based on a quotation offered from an unrelated third party accepted by the Group. In 2021, the negotiation was suspended due to the continued deterioration of underlying investment, and the Group impaired the investment to nil with an impairment loss of RMB10,000 for the year ended December 31, 2021.